InsidersTradesSigma
이연제약 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 이연제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 이연제약 has recorded 37 reports. Market capitalisation: €181.6bn. The latest transaction was disclosed on 12 March 2026 (Other). Among the most active insiders: 정순옥. The full history is free.
37
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
6 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,364 of 26,213 companies
22.9
score / 100
Value21
Quality25
FCF yld-3.6%
Earn yld-16%
EV/EBITDA19.4x
ROE6.8%
Gross mgn26%
Net mgn-20%
Debt/EBITDA10.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 March 2026
Declarations37 total
2,508,960 sharesKRXDART:20241029000243
Ideal exit: 22 Jul 2025 (T+270)
25 of 37 declarations